Share

    


Home / Search Results

Search Results

You searched for:

Improving patient access to clinical trials has long been a vexing issue for clinicians and patient advocates. Although trials are the backbone of cancer research, participation rates have remained unchanged in recent decades. As a result, more attention is being paid to the lack of diversity in clinical trial populations. The National Coalition for Cancer Survivorship (NCCS) held its 2019 Cancer Policy …
With the enormous pressures of COVID-19, the ever-increasing complexity of oncology care, and the persistent social factors that lead to medical injustice, it is difficult to think about tackling even one more job. Yet, we must, we can, and we do. Today I want to mention four specific areas that all cancer programs need to be watching, thinking about, and preparing for.
Oncology Issues sat down with Dr. Schilsky to look back on his career and look forward to future research breakthroughs in this era of COVID-19 and beyond.
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
Advancements in reproductive science has provided more options for women to take greater control of their reproductive future.
Lankenau Medical Center operationalized this joint ASCO-ACCC implicit bias aimed at ensuring patients with cancer in underrepresented groups have equitable access to care and clinical trials.
One important step toward supporting the health of Indigenous Peoples was the opening of the Center for Indigenous Cancer Research (CICR) at Roswell Park Comprehensive Cancer Center in January 2020. Its mission: to reduce the impact of cancer on Indigenous communities regionally, nationally, and internationally.
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.
With more than 25 years of oncology nursing experience and more than 18 years as an oncology nurse practitioner, Christa Braun-Inglis, MS, APRN-Rx, FNP-BC, AOCNP, has a wealth of clinical expertise.
One of the ways in which community oncology is helping to close gaps in cancer research is through participation in the National Cancer Institute Community Oncology Research Program clinical trials. The Lahey Health Cancer Institute, a part of the Beth Israel Lahey Health System, continues to expand access to clinical trials and, in particular, the NCI National Clinical Trials Network into the community …
A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.